Epidemiological aspects of HTLV-III infection in Italy

P. Rossi, M. Carbonari, R. Bonomo, M. Galli, P. E. Manconi, B. Scarpati, G. Scano, C. Gaetano, B. Ensoli, F. Aiuti

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

An epidemiological survey on the presence of serum antibodies to human T lymphotropic retrovirus III (HTLV-III) is reported. The study was carried out on people living in large as well as small cities in different Italian regions. Serum samples of 21 patients with AIDS, 402 with ARCS, and 920 from individuals at risk for these diseases were analyzed. The percentage of positive sera varied from 81% in AIDS, to 100% -33.3% in ARC according to the different geographical areas and/or the various categories of people with ARC. The percentage of positive sera in individuals at risk for AIDS or ARC varied from 11.9% in homosexuals, to 21% in drug abusers and 23.1% in haemophiliacs. No positive sera were observed among 660 normal individuals, relatives of patients with AIDS or ARC and in 114 patients suffering from immunological or infectious disease and among people at risk living in small cities. Sera were also negative in patients with classical Kaposi's sarcoma or T-cell chronic lymphocytic leukemia. Since none of the 660 unselected normal adults were positive while a significant percentage of people at risk for AIDS showed antibodies to HTLV-III, we may presume that this infection is prevalent in the Italian categories in which AIDS and ARC are most likely to develop.

Original languageEnglish
Pages (from-to)288-293
Number of pages6
JournalEuropean Journal of Epidemiology
Volume1
Issue number4
DOIs
Publication statusPublished - Dec 1985

Fingerprint

Retroviridae Infections
AIDS-Related Complex
Italy
Acquired Immunodeficiency Syndrome
Serum
Retroviridae
T-Cell Prolymphocytic Leukemia
HIV Antibodies
Kaposi's Sarcoma
Immune System Diseases
Drug Users
Communicable Diseases
Antibodies
Infection

Keywords

  • AIDS
  • Epidemiology
  • HTLV-III

ASJC Scopus subject areas

  • Epidemiology

Cite this

Rossi, P., Carbonari, M., Bonomo, R., Galli, M., Manconi, P. E., Scarpati, B., ... Aiuti, F. (1985). Epidemiological aspects of HTLV-III infection in Italy. European Journal of Epidemiology, 1(4), 288-293. https://doi.org/10.1007/BF00237104

Epidemiological aspects of HTLV-III infection in Italy. / Rossi, P.; Carbonari, M.; Bonomo, R.; Galli, M.; Manconi, P. E.; Scarpati, B.; Scano, G.; Gaetano, C.; Ensoli, B.; Aiuti, F.

In: European Journal of Epidemiology, Vol. 1, No. 4, 12.1985, p. 288-293.

Research output: Contribution to journalArticle

Rossi, P, Carbonari, M, Bonomo, R, Galli, M, Manconi, PE, Scarpati, B, Scano, G, Gaetano, C, Ensoli, B & Aiuti, F 1985, 'Epidemiological aspects of HTLV-III infection in Italy', European Journal of Epidemiology, vol. 1, no. 4, pp. 288-293. https://doi.org/10.1007/BF00237104
Rossi P, Carbonari M, Bonomo R, Galli M, Manconi PE, Scarpati B et al. Epidemiological aspects of HTLV-III infection in Italy. European Journal of Epidemiology. 1985 Dec;1(4):288-293. https://doi.org/10.1007/BF00237104
Rossi, P. ; Carbonari, M. ; Bonomo, R. ; Galli, M. ; Manconi, P. E. ; Scarpati, B. ; Scano, G. ; Gaetano, C. ; Ensoli, B. ; Aiuti, F. / Epidemiological aspects of HTLV-III infection in Italy. In: European Journal of Epidemiology. 1985 ; Vol. 1, No. 4. pp. 288-293.
@article{5dc9bf6f9da346198d4c57f6000fcb64,
title = "Epidemiological aspects of HTLV-III infection in Italy",
abstract = "An epidemiological survey on the presence of serum antibodies to human T lymphotropic retrovirus III (HTLV-III) is reported. The study was carried out on people living in large as well as small cities in different Italian regions. Serum samples of 21 patients with AIDS, 402 with ARCS, and 920 from individuals at risk for these diseases were analyzed. The percentage of positive sera varied from 81{\%} in AIDS, to 100{\%} -33.3{\%} in ARC according to the different geographical areas and/or the various categories of people with ARC. The percentage of positive sera in individuals at risk for AIDS or ARC varied from 11.9{\%} in homosexuals, to 21{\%} in drug abusers and 23.1{\%} in haemophiliacs. No positive sera were observed among 660 normal individuals, relatives of patients with AIDS or ARC and in 114 patients suffering from immunological or infectious disease and among people at risk living in small cities. Sera were also negative in patients with classical Kaposi's sarcoma or T-cell chronic lymphocytic leukemia. Since none of the 660 unselected normal adults were positive while a significant percentage of people at risk for AIDS showed antibodies to HTLV-III, we may presume that this infection is prevalent in the Italian categories in which AIDS and ARC are most likely to develop.",
keywords = "AIDS, Epidemiology, HTLV-III",
author = "P. Rossi and M. Carbonari and R. Bonomo and M. Galli and Manconi, {P. E.} and B. Scarpati and G. Scano and C. Gaetano and B. Ensoli and F. Aiuti",
year = "1985",
month = "12",
doi = "10.1007/BF00237104",
language = "English",
volume = "1",
pages = "288--293",
journal = "European Journal of Epidemiology",
issn = "0393-2990",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Epidemiological aspects of HTLV-III infection in Italy

AU - Rossi, P.

AU - Carbonari, M.

AU - Bonomo, R.

AU - Galli, M.

AU - Manconi, P. E.

AU - Scarpati, B.

AU - Scano, G.

AU - Gaetano, C.

AU - Ensoli, B.

AU - Aiuti, F.

PY - 1985/12

Y1 - 1985/12

N2 - An epidemiological survey on the presence of serum antibodies to human T lymphotropic retrovirus III (HTLV-III) is reported. The study was carried out on people living in large as well as small cities in different Italian regions. Serum samples of 21 patients with AIDS, 402 with ARCS, and 920 from individuals at risk for these diseases were analyzed. The percentage of positive sera varied from 81% in AIDS, to 100% -33.3% in ARC according to the different geographical areas and/or the various categories of people with ARC. The percentage of positive sera in individuals at risk for AIDS or ARC varied from 11.9% in homosexuals, to 21% in drug abusers and 23.1% in haemophiliacs. No positive sera were observed among 660 normal individuals, relatives of patients with AIDS or ARC and in 114 patients suffering from immunological or infectious disease and among people at risk living in small cities. Sera were also negative in patients with classical Kaposi's sarcoma or T-cell chronic lymphocytic leukemia. Since none of the 660 unselected normal adults were positive while a significant percentage of people at risk for AIDS showed antibodies to HTLV-III, we may presume that this infection is prevalent in the Italian categories in which AIDS and ARC are most likely to develop.

AB - An epidemiological survey on the presence of serum antibodies to human T lymphotropic retrovirus III (HTLV-III) is reported. The study was carried out on people living in large as well as small cities in different Italian regions. Serum samples of 21 patients with AIDS, 402 with ARCS, and 920 from individuals at risk for these diseases were analyzed. The percentage of positive sera varied from 81% in AIDS, to 100% -33.3% in ARC according to the different geographical areas and/or the various categories of people with ARC. The percentage of positive sera in individuals at risk for AIDS or ARC varied from 11.9% in homosexuals, to 21% in drug abusers and 23.1% in haemophiliacs. No positive sera were observed among 660 normal individuals, relatives of patients with AIDS or ARC and in 114 patients suffering from immunological or infectious disease and among people at risk living in small cities. Sera were also negative in patients with classical Kaposi's sarcoma or T-cell chronic lymphocytic leukemia. Since none of the 660 unselected normal adults were positive while a significant percentage of people at risk for AIDS showed antibodies to HTLV-III, we may presume that this infection is prevalent in the Italian categories in which AIDS and ARC are most likely to develop.

KW - AIDS

KW - Epidemiology

KW - HTLV-III

UR - http://www.scopus.com/inward/record.url?scp=0022373391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022373391&partnerID=8YFLogxK

U2 - 10.1007/BF00237104

DO - 10.1007/BF00237104

M3 - Article

VL - 1

SP - 288

EP - 293

JO - European Journal of Epidemiology

JF - European Journal of Epidemiology

SN - 0393-2990

IS - 4

ER -